Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
05/24/1994 | US5314688 Local delivery of dipyridamole for the treatment of proliferative diseases |
05/24/1994 | CA2109537A1 Trans and cis traumatic acid salts having cicatrizant activity associated to bacteriostatic, antiviral, antibiotic or antifungal activity |
05/24/1994 | CA2019618C Zinc compound delivery system with improved taste and texture |
05/24/1994 | CA1329862C Aryloxy and arylacyloxy methyl ketones as thiol protease inhibitors |
05/24/1994 | CA1329807C Cardiotonic tricyclic imidazolones |
05/24/1994 | CA1329805C Method of preparing solid lactulose |
05/24/1994 | CA1329775C Edible, baked compositions containing cholestyramine |
05/24/1994 | CA1329774C Methods for the treatment of osteoporosis and related disorders |
05/24/1994 | CA1329773C Pharmaceutical compositions useful for the treatment of uremia |
05/24/1994 | CA1329772C Use of 2-amino-4-morpholino-6-propyl-1,3,5-triazine for the preparation of medicaments for the treatment of cognitive and behavioral disorders associated with aging and with dementia syndromes |
05/24/1994 | CA1329771C Angiogenesis inhibitory agent |
05/24/1994 | CA1329770C 17-methylene- and 17-ethylidene-estratrienes |
05/24/1994 | CA1329763C Stabilized fgf composition and production thereof |
05/24/1994 | CA1329761C Design of peptide hormones, chemotactic peptides and drug compounds |
05/21/1994 | CA2108848A1 Vitamin d3 analogs |
05/21/1994 | CA2103381A1 N,n-disubstituted arylcycloalkylamines |
05/19/1994 | DE4300697C1 New 2-pyrrolidino-ethyl ester of ketorolac - useful as analgesic, antiinflammatory and antipyretic agent with low ulcerogenicity |
05/19/1994 | DE4238367A1 Diuretisches Mittel Diuretic agents |
05/19/1994 | DE4238233A1 Inhibiting 5- or 15-lipoxygenase or cyclo:oxygenase - using N-sulphonyl-aminophenol derivs., e.g. for treating asthma, inflammation or allergy |
05/19/1994 | DE4238032A1 Hautkonditionierende Bernsteinsäure-Derivate Skin conditioning succinic acid derivatives |
05/19/1994 | CA2103294A1 Topical pharmaceutical composition for respiratory allergies |
05/19/1994 | CA2103203A1 Pharmaceutical compounds |
05/19/1994 | CA2102931A1 Process and intermediates for the preparation of excitatory amino acid receptor antagonists |
05/18/1994 | EP0597540A1 Aryl-fused and hetaryl-fused-2,4-diazocine antiarrhythmic agents |
05/18/1994 | EP0597429A2 Process for the production of 3-vinylcephalosporins |
05/18/1994 | EP0597423A2 Azetidinone compound and process for preparation thereof |
05/18/1994 | EP0597415A1 Saccharose octasulfate ferric complex therapy |
05/18/1994 | EP0597414A2 Stable formulation of Senna extract |
05/18/1994 | EP0597377A1 Process for the production of 3,7-Dialkylxanthine from 3-Alkylxanthine |
05/18/1994 | EP0597304A1 Use of substituted benzimidazoles |
05/18/1994 | EP0597303A2 Cephalosporin derivatives |
05/18/1994 | EP0597291A1 2,3-diphenyl-5-pyrrolyl-furan derivatives, processes and intermediates for their preparation and their use as anti-inflammatory, and anti-allergic and platelet aggregation inhibiting agents |
05/18/1994 | EP0597130A1 Antirheumatic |
05/18/1994 | EP0597107A1 Lignan analog, production thereof, and hypolipidemic drug |
05/18/1994 | EP0597088A1 Novel imidazole derivatives, their preparation and therapeutic applications |
05/18/1994 | EP0597071A1 Androgens for stimulating the central nervous system and for treating osteoporosis |
05/18/1994 | EP0597049A1 Antifungal agents |
05/18/1994 | EP0597025A1 Use of a tocopherol phosphate or one of its derivatives, for the preparation of cosmetic or pharmaceutical compositions and compositions so obtained |
05/18/1994 | EP0597018A1 Novel glycoside compounds and production and use thereof |
05/18/1994 | EP0597003A1 Quinoline derivatives as immunostimulants |
05/18/1994 | EP0596970A1 Prostaglandin-e 1? formulation |
05/18/1994 | EP0596943A1 Process for purifying pentostatin. |
05/18/1994 | EP0596937A1 Plasmalopsychosines and plasmalocerebrosides and methods of treating neuronal diseases employing the same |
05/18/1994 | EP0596935A1 Antiviral pharmaceutical compositions for vaginal administration. |
05/18/1994 | EP0596933A1 5-ht4 receptor antagonists |
05/18/1994 | EP0596917A1 Benzimidazole anthelmintics |
05/18/1994 | EP0596912A1 Modulation and diagnosis of cytokine dysfunctions |
05/18/1994 | EP0596897A1 Hydroisoquinoline derivatives |
05/18/1994 | EP0596891A1 Aminoalkyl-substituted 2-amino-5-mercaptothiadiazoles, their preparation and their use |
05/18/1994 | EP0596876A1 Chelator compositions comprising alpha-diamine compounds |
05/18/1994 | EP0555210A4 Microbiocidal combinations of materials and their use |
05/18/1994 | EP0548177B1 5-aminosalicylic acid derivatives for the therapy of chronic inflammatory bowel diseases |
05/18/1994 | EP0537139B1 Process for producing pressed, moulded, delayed release dose units and dose units thus produced |
05/18/1994 | EP0409949B1 Arylsulphonyl-nitromethanes, process for their preparation and pharmaceutical compositions |
05/18/1994 | CN1086825A The present invention is concerned with tri- and tetracyclic compounds |
05/18/1994 | CN1086821A Novel thio-substituted cyclic phosphonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism |
05/18/1994 | CN1086820A Phenol substituted gem-diphosphonate derivatives, process for their preparation and pharmaceutical compositions containing them |
05/18/1994 | CN1086819A Novel compounds |
05/18/1994 | CN1086818A Asymmetrically substituted xanthines |
05/18/1994 | CN1086816A Method for the preparation of ethanolamine derivatives |
05/18/1994 | CN1086815A 2-(1-hydroxyethyl)-5-hydroxynaphthoÛ2,3-BÙfuran-4, 9-dione and antitumor agents comprising this compound |
05/18/1994 | CN1086813A 3- and 5-substituted 1,2,3,4-oxatriazole-5-imine compounds, a process for the preparation thereof, a pharmaceutical preparation containing said compounds and the use of said compounds for TH |
05/18/1994 | CN1086812A Process for preparing novel aromatase inhibiting 4(5)-imidazoles |
05/18/1994 | CN1086811A Novel nicotincacid esters |
05/18/1994 | CN1086809A 5-OXO-dibenzo (a,d) cyclohepta-1, 4-dienes |
05/18/1994 | CN1086806A Substituted cyclohexane derivative for treatment of illness |
05/18/1994 | CN1086711A Compound hypotensor |
05/18/1994 | CN1086710A Henbane drug give-up agent and its preparation and use |
05/18/1994 | CN1086709A Compositions containing retionic acids and tocopherol |
05/18/1994 | CN1086708A Memanting-containing solid pharmaceutical dosage forms having an extended two-stage release profile and production thereof |
05/18/1994 | CN1024557C Process for composition containing associated compound of hyaluronic acid |
05/18/1994 | CN1024555C Process for phenol substituted gem-diphosphonate derivatives |
05/18/1994 | CN1024554C Antibacterial-2 carbapenem derivatives preparation method |
05/18/1994 | CN1024552C Process for pyridoindole derivatives |
05/18/1994 | CN1024551C Process for indole derivatives |
05/18/1994 | CN1024550C Optical resolution method for 3R-(3-carboxybenzyl)-6-(5-fluoro-2-benzothiazolyl) methoxy-4R-chromanol |
05/18/1994 | CN1024548C Process for cyclic amine compound |
05/18/1994 | CN1024547C Process for preparing cyclic amine compound |
05/18/1994 | CN1024545C Preparation for 4-demethoxy-4-amino-zhendinmycin-one |
05/18/1994 | CN1024498C Process for medical compound containing carboxymethyl starch sodium |
05/18/1994 | CN1024497C Method for preparing stable medicine suspending liquid of ximeitidin |
05/18/1994 | CA2109186A1 Aminocarbonyl (thiocarbonyl) and cyanoguanidine derivatives of quinoline and indoline |
05/17/1994 | US5312985 Method of synthesizing the precursor pyruvamide |
05/17/1994 | US5312968 Compounds for skin lubrication |
05/17/1994 | US5312961 Antiglaucoma and antispasmodic agents |
05/17/1994 | US5312936 Angiotensin II antagonists |
05/17/1994 | US5312925 Neuroleptic agents |
05/17/1994 | US5312916 Hydrogenating 6-phthalimidomethyl-5H-dibenz/b,e/azepine with palladium/charcoal, reacting product with hydrazine, reacting product with bromocyanogen, precipitating in presence of dimethylformamide and hydrogen chloride |
05/17/1994 | US5312842 Cyclopentane heptenylsulfinylalkyl and heptanylsulfinylalkyl-2-aliphatic or aryl aliphatic derivatives |
05/17/1994 | US5312840 Substituted guanidines having high binding to the sigma receptor and the use thereof |
05/17/1994 | US5312839 Aminoalkylsulfonic acids for cells |
05/17/1994 | US5312837 Method of treating viral infections with aryl macrocyclic compounds |
05/17/1994 | US5312836 Short chain triglycerides |
05/17/1994 | US5312835 Use of cardiotonic drugs and inhibitors of nitric oxide synthesis to alleviate pathologic hypotension |
05/17/1994 | US5312834 Eicosapentenoic acid, a-linolenic acid |
05/17/1994 | US5312833 Method of inhibiting tumor growth using xanthocillin X dimethylether |
05/17/1994 | US5312832 Ocular hypotensive 2-decarboxyl-2-acylthioalkyl prostaglandin derivatives |
05/17/1994 | US5312831 Immunology, anticarcinogenic agents and AIDS treatment |
05/17/1994 | US5312830 Antiinflammatory agents |
05/17/1994 | US5312827 Nitrosamine-free-3-isothiazolones and process |